Kastrisiou, M.; Zarkavelis, G.; Kougioumtzi, A.; Sakaloglou, P.; Kostoulas, C.; Georgiou, I.; Batistatou, A.; Pentheroudakis, G.; Magklara, A.
Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer. Diagnostics 2021, 11, 2375.
https://doi.org/10.3390/diagnostics11122375
AMA Style
Kastrisiou M, Zarkavelis G, Kougioumtzi A, Sakaloglou P, Kostoulas C, Georgiou I, Batistatou A, Pentheroudakis G, Magklara A.
Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer. Diagnostics. 2021; 11(12):2375.
https://doi.org/10.3390/diagnostics11122375
Chicago/Turabian Style
Kastrisiou, Myrto, George Zarkavelis, Anastasia Kougioumtzi, Prodromos Sakaloglou, Charilaos Kostoulas, Ioannis Georgiou, Anna Batistatou, George Pentheroudakis, and Angeliki Magklara.
2021. "Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer" Diagnostics 11, no. 12: 2375.
https://doi.org/10.3390/diagnostics11122375
APA Style
Kastrisiou, M., Zarkavelis, G., Kougioumtzi, A., Sakaloglou, P., Kostoulas, C., Georgiou, I., Batistatou, A., Pentheroudakis, G., & Magklara, A.
(2021). Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer. Diagnostics, 11(12), 2375.
https://doi.org/10.3390/diagnostics11122375